Date: 2024/10/19 - 19:40
NIH clinical trial results expand treatment options for this disease.
NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.
Date: 2024/10/19 - 01:25
NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of future behavioral health-related emergency department and inpatient care.
NIH takes very seriously allegations of research misconduct.
NIH-supported milestone will advance understanding of brain processes in larger animals.